ACRS Stock Analysis: Buy, Sell, or Hold?
ACRS - Aclaris Therapeutics, Inc.
$3.51
0.08 (2.33%)
▲
5d:
-22.0%
30d:
+21.03%
90d:
+50.0%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
23d
Get Alerted When ACRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ACRS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ACRS is down 22.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ACRS is down 22.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACRS is currently trading at $3.51, which is considered slightly high relative to its 30-day fair value range of $2.57 to $3.84.
Technical Outlook: Technically, ACRS is in a strong uptrend. Immediate support is located at $2.61, while resistance sits at $4.89.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.67 (+118.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACRS is in a strong uptrend. Immediate support is located at $2.61, while resistance sits at $4.89.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.67 (+118.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$2.57 -
$3.84
Company Quality Score
57/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 118.4% below Wall St target ($7.67)
- WARNING: Recommendation downgraded due to -22.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.57 -
$3.84
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.61
Resistance Level
$4.89
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.18
Wall Street Target
$7.67
(+118.4%)
Revenue Growth (YoY)
-24.1%
Last updated: February 01, 2026 11:02 PM ET
Data refreshes hourly during market hours. Next update: 12:02 AM
Data refreshes hourly during market hours. Next update: 12:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
